We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Two leading experts have been appointed as members of the Advisory Council on the Misuse of Drugs.
The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine.
Government launches consultation to help combat rising drug deaths from opioids, as part of record £3.4 billion in investment in drug and alcohol services.
Dame Carol Black GBE has been appointed to the role of independent adviser to the UK government on drugs for a 3-year term until November 2028.
Professor Wood will replace Owen Bowden-Jones as chair on 1 January 2026.
The government has launched a new campaign to alert young people to the dangers of ketamine, counterfeit medicines and adulterated THC vapes.
Letter from Minister Johnson to the Chair of the Advisory Council on the Misuse of Drugs (ACMD) setting out the priorities for ACMD's work programme.
A new study published by UKHSA shows some bacteria have already become resistant to one of the newest antibiotics introduced to the NHS.
Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2025.
Government response to the ACMD's advice on increasing the level of tetrahydrocannabinol (THC) permissible in industrial hemp from 0.2-0.3% and assessment after 2 years.
Four more experts have been appointed members to the Advisory Council on the Misuse of Drugs.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine.
Changes to the Misuse of Drugs Act 1971 to control 22 substances, with 2-benzyl benzimidazole variants (nitazenes) falling under a new generic definition.
Ten leading experts have joined the Advisory Council on the Misuse of Drugs (ACMD) to strengthen its vital work advising the government on drug harms.
The government will seek expert advice on reclassifying ketamine to become a Class A substance.
The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.
The government will fund research into wearable technology, virtual reality and artificial intelligence in a bid to support people with drug addictions.
Legislation has been laid in Parliament to ban xylazine and 21 other dangerous drugs.
Confiscated and surrendered drugs will be tested to identify toxic substances in circulation and help prevent drug-related overdoses.
First published during the 2022 to 2024 Sunak Conservative government
The government responds to the ACMD's report on recently encountered novel benzodiazepines and related compounds.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).